Photo-activated riboflavin therapy of refractory corneal ulcers

Cornea

Volumn 31, Issue 10, 2012, Pages 1210-1213

  Panda, Anita ^a   Krishna, Sasikala N ^a   Kumar, Sandeep ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

corneal collagen cross linking; keratitis; photo activated ribo flavin; riboflavin

Indexed keywords

ACICLOVIR; CEFAZOLIN; CHLORHEXIDINE; NATAMYCIN; PROPAMIDINE ISETHIONATE; RIBOFLAVIN; TOBRAMYCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CORNEA ULCER; FEMALE; HUMAN; KERATITIS; MALE; PHOTOACTIVATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; CORNEAL ULCER; EYE INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; TREATMENT OUTCOME; ULTRAVIOLET RAYS; VISUAL ACUITY;

EID: 84866238946     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31823f8f48     Document Type: Article

References (31)

1. Thylefors B, Négrel AD, Pararajasegaram R, et al. Available data on blindness (update 1994). Ophthalmic Epidemiol. 1995;2:5-39.
2. Upadhyay MP, Karmacharya PC, Koirala S, et al. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol. 1991;111:92-99.
3. Panda A, Satpathy G, Nayak N, et al. Demographic pattern, predisposing factors and management of ulcerative keratitis: evaluation of one thousand unilateral cases at a tertiary care centre. Clin Experiment Ophthalmol. 2007;35:44-50. (Pubitemid 46195927)
4. Wong T, Ormonde S, Gamble G, et al. Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol. 2003;87:1103-1108. (Pubitemid 37064885)
5. Panda A, Khokhar S, Rao V, et al. Therapeutic penetrating keratoplasty in nonhealing corneal ulcer. Ophthalmic Surg. 1995;26:325-329.
6. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627. (Pubitemid 36457967)
7. Hafezi F, Kanellopoulos J, Wiltfang R, et al. Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J Cataract Refract Surg. 2007;33:2035-2040. (Pubitemid 350167516)
8. Schnitzler E, Spörl E, Seiler T. Irradiation of cornea with ultraviolet light and riboflavin adminstration as a new treatment for erosive corneal processes, preliminary results in four patients [in German]. Klin Monbl Augenheilkd. 2000;217:190-193.
9. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35-40. (Pubitemid 39389439)
10. Iseli HP, Thiel MA, Hafezi F, et al. Ultraviolet A/riboflavin corneal crosslinking for infectious keratitis associated with corneal melts. Cornea. 2008; 27:590-594.
11. Micelli Ferrari T, Leozappa M, Lorusso M, et al. Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal cross-linking: a case report. Eur J Ophthalmol. 2009;19:295-297.
12. Kozobolis V, Labiris G, Gkika M, et al. UV-A collagen cross-linking treatment of bullous keratopathy combined with corneal ulcer. Cornea. 2010;29:235-238.
13. Makdoumi K, Mortensen J, Crafoord S. Infectious keratitis treated with corneal crosslinking. Cornea. 2010;29:1353-1358.
14. Morén H, Malmsjö M, Mortensen J, et al. Riboflavin and ultraviolet A collagen crosslinking of the cornea for the treatment of keratitis. Cornea. 2010;29:102-104.
15. Khan YA, Kashiwabuchi RT, Martins SA, et al. Riboflavin and ultraviolet light A therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology. 2011;118: 324-331.
16. Spoerl E, Raiskup F, Kampik D, et al. Correlation between UV absorption and riboflavin concentration in different depths of the cornea in CXL. Curr Eye Res. 2010;35:1040-1041.
17. Knutson F, Alfonso R, Dupuis K, et al. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang. 2000;78: 209-216. (Pubitemid 30481251)
18. Goodrich RP. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang. 2000;78(suppl 2):211-215.
19. Isola H, Kientz D, Aleil B, et al. In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set. Vox Sang. 2006;90:128-130. (Pubitemid 43381501)
20. Corbin F III. Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer. Int J Hematol. 2002;76(suppl 2):253-257.
21. Grellier P, Benach J, Labaied M, et al. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components. Transfusion. 2008;48: 1676-1684.
22. Reddy HL, Dayan AD, Cavagnaro J, et al. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev. 2008;22:133-153. (Pubitemid 351384824)
23. Martins SA, Combs JC, Noguera G, et al. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008;49:3402-3408.
24. Khanal B, Deb M, Panda A, et al. Laboratory diagnosis in ulcerative keratitis. Ophthalmic Res. 2005;37:123-127.
25. Wollensak G, Iomdina E, Dittert DD, et al. Wound healing in the rabbit cornea after corneal collagen cross-linking with riboflavin and UVA. Cornea. 2007;26:600-605. (Pubitemid 47164721)
26. Wang F. UVA/riboflavin-induced apoptosis in mouse cornea. Ophthalmologica. 2008;222:369-372.
27. Takami Y, Gong H, Amemiya T. Riboflavin deficiency induces ocular surface damage. Ophthalmic Res. 2004;36:156-165. (Pubitemid 38586122)
28. Bertollo CM, Oliveira AC, Rocha LT, et al. Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models. Eur J Pharmacol. 2006;547:184-191. (Pubitemid 44373905)
29. Ehlers N, Hjortdal J. Riboflavin-ultraviolet light induced crosslinking in endothelial decompensation. Acta Ophthalmol. 2008;86: 549-551.
30. Hafezi F, Dejica P, Majo F. Modified corneal collagen crosslinking reduces corneal oedema and diurnal visual fluctuations in Fuchs dystrophy. Br J Ophthalmol. 2010;94:660-661.
31. Wollensak G, Aurich H, Pham DT, et al. Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A. J Cataract Refract Surg. 2007;33:516-521. (Pubitemid 46281575)